What Biocientifica does

Biocientifica S.A. is an Argentine biotechnology company founded in 1983 by Dr. Roberto Sedlinsky in Buenos Aires. The company develops, manufactures, and commercializes in vitro diagnostic (IVD) reagents and research-use-only (RUO) products, anchored by three proprietary lines: the Schep Real-Time PCR portfolio (including kits for dengue virus types 1–4, SARS-CoV-2 and Omicron BA.1/BA.2 variants, influenza A/B, and BCR-ABL1 p210 leukemia monitoring), the Inmunofluor immunofluorescence line (35+ products for autoimmune and infectious disease diagnosis, originally developed through reverse engineering during the 1982 Falklands War embargo), and the Diffu-Plate radial immunodiffusion line for quantification of clinically relevant human proteins. Core underlying technologies span RT-PCR with hot-start enzymes and dualplex/multiplex probe architectures, ELISA, linear immunoassay, immunofluorescence (direct and indirect), and nucleic acid extraction and purification; the company also serves as the Argentine distributor for international life-sciences brands such as Macherey Nagel, Solis BioDyne, Aesku Diagnostics, Human GmbH, Virion Serion, PeproTech, Abcam, MP Biomedicals, Yourgene, and Meridian. Manufacturing takes place at a GMP-compliant, ANMAT-enabled, ISO 13485-certified plant (DNV-accredited) in Buenos Aires, and most in-house products carry CE marking for EU sale via Authorized Representative Medical Technology Promedt Consulting GmbH.

The business operates on three revenue streams. The first is direct sale of own-brand IVD kits, sold per transaction to clinical laboratories, hospital laboratories, and pathology labs. The second is import and resale of international life-sciences brands in Argentina, generating margin on distributed SKUs across molecular biology, immunology, and research reagents. The third is contract development and manufacturing (OEM/private-label), offering regulatory documentation, validation, industrial scaling, packaging, and distribution for third-party clients targeting the Argentine and Latin American markets. Go-to-market combines direct sales (HQ plus regional offices in Litoral, Mendoza, and Córdoba), a network of 25+ Argentine distributors and biochemistry colleges, an exclusive Latin American distribution agreement with IMMULAB (Paragon Care, Australia) for transfusion medicine, and an international distributor network covering 20 countries in Latin America, Europe, Asia, and Africa. Customer segments span clinical diagnostic laboratories, hospitals, academic and biomedical research institutions, epidemiology and public health centers, agrobiotechnology and food safety laboratories, pharmaceutical and biotech firms, petrochemical industries, and seed companies. A community-led education and training model — including open-access materials, university reagent donations, and scientific event participation — supports demand generation and brand loyalty among biochemists and bioscience researchers.

Name

Biocientifica

Legal name

Biocientifica S.A.

Website

https://biocientifica.com.ar

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Biocientifica S.A. develops, manufactures, and commercializes in vitro diagnostic (IVD) reagents and biological research products in Argentina, exporting to 20 countries through proprietary Schep RT-PCR, Inmunofluor, and Diffu-Plate lines, while distributing international life-sciences brands and offering OEM/CDMO services to laboratories, hospitals, universities, and biotech, agro, and food-safety industries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)

Keywords

• In vitro diagnostics
• Molecular diagnostics
• Immunofluorescence reagents
• PCR test kits
• Biotechnology manufacturing

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Own IVD Product Sales (Argentina and Export): Biocientifica develops, manufactures, and commercializes its own in vitro diagnostic (IVD) reagents under the Schep, Inmunofluor, and Diffu-Plate brands. These products are sold as one-time purchases (per kit/unit) to clinical laboratories, hospitals, and research institutions. Products are ANMAT-approved (Argentina) and carry CE marking for the European Union.
2. Imported Life Sciences Product Distribution (Argentina): The company imports and resells internationally branded life sciences products in Argentina, including reagents, equipment, and consumables from partner brands such as Macherey Nagel, Solis BioDyne, Aesku Diagnostics, Human Diagnostics, Virion Serion, PeproTech, Abcam, MP Biomedicals, Eurofins Genomics, Yourgene, Meridian, and others. Revenue is generated through the mark-up on imported products sold domestically.
3. Contract Development and Manufacturing (OEM/Private Label): Biocientifica offers contract development and manufacturing services including product development (OEM or private label), validation studies, regulatory documentation, industrial scaling, quality control, packaging, marketing, sales representation, and logistics/distribution for third-party clients in Argentina and abroad. This includes development of products under the client's own brand for sale in Argentina and Latin America.
4. Training, Education, and Community Services: The company generates revenue through community engagement services including training events, professional update publications, free educational materials, and support for research institutions, universities, and scientific events. This supports customer retention and brand loyalty across the core product lines.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Biocientifica develops, produces, and commercializes in vitro diagnostic (IVD) reagents and biological research products (RUO) under its proprietary Schep, Inmunofluor, and Diffu-Plate brands, covering Real-Time PCR kits (dengue, SARS-CoV-2, influenza, leukemia monitoring), immunofluorescence reagents (35+ products for autoimmune and infectious diseases), and radial immunodiffusion plates. The company also imports and distributes international life sciences brands in Argentina and offers OEM/contract development and manufacturing services to third parties.

Product overview

Biocientifica is a biotechnology company that develops, produces, and commercializes in vitro diagnostic reagents (IVD) and research products (RUO). Their core product lines include the Schep line for Real-Time PCR diagnostics (covering dengue, SARS-CoV-2, influenza, and leukemia monitoring), the Inmunofluor line for immunofluorescence (35+ products for infectious and autoimmune diseases), and Diffu-Plate for radial immunodiffusion. They also distribute internationally recognized brands including Aesku Diagnostics (ELISA autoimmune tests), Human GmbH (ANA-LIA line immunoassays), Virion Serion (SERION ELISA Classic), Macherey Nagel (NucleoSpin nucleic acid extraction kits), Solis BioDyne (FIREPol PCR/qPCR enzymes), and IMMULAB (transfusional medicine products). The company operates under ISO 13485 certification and GMP standards, with ANMAT authorization and CE marking for European sales.

Differentiator

Problem solved

Functional benefit

Brands

• Schep: Line of Real-Time PCR diagnostic products including SARS-CoV-2, Dengue, Influenza A/B, and oncology (BCR-ABL1 p210) detection kits. The Schep line is 100% Argentine biotechnology developed in-house.
• Inmunofluor
• IMMULAB

Products and services

• Schep Dengue Screen First Argentine R&D kit for dengue based on Real-Time PCR technology. Qualitative one-step RT-PCR test for reverse transcription, amplification, and detection of specific regions of dengue virus types 1, 2, 3, and 4 from extracted RNA samples of human serum. Approved by ANMAT. For clinical laboratories and epidemiological surveillance centers.
• Schep SARS-CoV-2 Multi-FAST Rapid diagnostic PCR test for SARS-CoV-2 detection in multiplex format in one step. Detects three viral genes (Envelope E, Nucleocapside N, and Spike S) with internal control for extraction and amplification verification. Validated on Rotor-Gene Q, Applied Biosystems 7500, LineGene 9600, and QuantStudio 5. For clinical and hospital laboratories.
• SCHEP BCR-ABL1 p210 CUANTIPLEX First 100% Argentine molecular diagnostic kit for oncology. RT-qPCR kit for the quantitative detection of BCR-ABL1 p210 mRNA (e13a2 and e14a2 isoforms) and ABL1 reference gene from peripheral blood and bone marrow samples of patients with CML, AML, and ALL. Dualplex integrated into a single Master Mix (MM210), harmonized with the International Scale (IS). ANMAT-approved IVD.
• Schep SARS-CoV-2 Omicron BA.1 / BA.2 kits Duplex RT-PCR kits for real-time amplification and detection of SARS-CoV-2 Omicron BA.1 and BA.2 variants in a single step. For clinical laboratories performing variant surveillance.
• Línea Inmunofluor Immunofluorescence product line with over 35 products for infectious and autoimmune diseases. Includes kits for Chlamydia trachomatis, FTA-ABS (syphilis), EMA IgA (celiac disease), and various control positive products. Originally developed through reverse engineering during the 1982 Falklands War embargo; exported to 15+ countries. For clinical and pathology laboratories.
• Línea Diffu-Plate Radial immunodiffusion plates for quantification of clinically relevant human proteins in sera and biological fluids. Reference method for protein measurement with precise and exact results and flexible sample throughput. Cost-effective alternative to nephelometry and turbidimetry. For clinical laboratories.
• Línea IMMULAB (Transfusional Medicine) Distributed product line for transfusion medicine including Epiclone monoclonal antibodies (ABO), Abtectcell antibody detection cells, Revercell reverse grouping cells, Phenocell antibody identification panels, and Securacell quality control reagents. Exclusive distribution for Argentina and Latin America under the IMMULAB/Paragon Care agreement. For blood banks, hospitals, and transfusion services.
• AESKULISA product line (Aesku Diagnostics) Distributed ELISA assays for autoimmune disease diagnosis including ANA-8 Pro, ASCA-A, CCP (rheumatoid arthritis), DGP-GA, MPO (vasculitis), tTg-GA (celiac disease), and various antibody detection tests. For clinical laboratories.
• ANA-LIA product line (Human GmbH) Distributed line immunoassays for autoimmune disease screening and diagnosis including ANA-LIA (12 antibodies), ANA-LIA MAXX (17 antibodies), ANA-LIA XL (18 antibodies), and disease-specific panels. For clinical laboratories.
• Línea SERION ELISA Classic (Virion Serion) Distributed qualitative and quantitative ELISA kits for determination of IgG or IgM antibodies against specific pathogens in serum or plasma. For clinical laboratories performing infectious disease serology.
• NucleoSpin product line (Macherey Nagel) Distributed nucleic acid extraction and purification kits including RNA Virus, Virus, Blood, Plant II, RNA Plant, Soil, Plasmid, Food, and Microbiome kits using silica membrane technology. For molecular biology and biomedical research laboratories.
• FIREPol / HOT FIREPol product line (Solis BioDyne) Distributed PCR and qPCR enzymes and master mixes including DNA polymerase, EvaGreen qPCR mixes, and probe qPCR mixes with stability TAG technology for ambient temperature stability. For biomedical research and molecular biology laboratories.
• FIREScript product line (Solis BioDyne) Distributed MMLV-based reverse transcriptase for cDNA synthesis from RNA and DNA templates with activity across a wide temperature range (37° to 60°C). For molecular biology and biomedical research laboratories.
• OEM / Contract Development and Manufacturing Services Contract development and manufacturing services including product development (OEM or private label), validation studies, regulatory documentation, industrial scaling, quality control, packaging, marketing, sales representation, and logistics/distribution for third-party clients in Argentina and Latin America. For pharmaceutical and biotech companies seeking to launch diagnostic or life sciences products in the region.

Quantifiable outcome

• First Argentine molecular oncology diagnostic kit (BCR-ABL1 p210 CUANTIPLEX) for leukemia monitoring, approved by ANMAT
• +2 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core and minor.

• IMMULAB (Paragon Care Group)coreChannel Partner/ Reseller/ Distributor · 8 August 2023IMMULAB, a leading provider of transfusion medicine products and part of the Australian Paragon Care group, signed an exclusive distribution agreement with Biocientifica for Argentina and all of Latin America. Biocientifica is IMMULAB's exclusive distributor for the entire continent. IMMULAB products represent the highest quality standards for transfusion medicine, hemotherapy, and blood bank services. This alliance marks the entry of IMMULAB into Latin America and the entry of Biocientifica into the field of transfusion medicine.
• Argentine Chamber of Biotechnology (Cámara Argentina de Biotecnología)minorStrategic or Co-development Partner · 1 May 2022Biocientifica became a member of the Argentine Chamber of Biotechnology (CAB), joining the organization that brings together the main actors in biotechnology in Argentina. This membership supports the company's strategic positioning in the national biotech ecosystem and facilitates collaboration with other industry players.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Wiener Laboratorios S.A.I.C. Argentine IVD and clinical diagnostics manufacturer offering reagents, instruments, and kits across immunology, biochemistry, hematology, and molecular diagnostics. Closest Argentine-headquartered competitor with overlapping ANMAT-registered IVD reagent portfolio serving clinical laboratories.
• Lemos Laboratorios: Argentine IVD manufacturer focused on immunoassay, serology, and infectious disease diagnostics. Directly comparable in product mix (ELISA, immunofluorescence, agglutination tests) and Argentine market positioning against Biocientifica.

Broad incumbents

• bioMérieux: Global IVD and microbiology multinational with deep presence in clinical diagnostics and industrial applications. BioMérieux was Biocientifica's original 2002 partner for launching its molecular diagnostics division, making it both a historical partner and a broad incumbent competing across Biocientifica's portfolio.
• Bio-Rad Laboratories: Global life science and clinical diagnostics company with broad portfolios in immunoassays, PCR/qPCR reagents, and quality controls. Overlaps directly with Biocientifica's immunology and molecular biology product lines and is represented through Bio-Rad's regional distributors in Latin America.
• Roche Diagnostics: Largest global IVD player with extensive molecular, immunoassay, and clinical chemistry portfolios. Competes with Biocientifica across infectious disease (dengue, SARS-CoV-2, influenza), autoimmune, and oncology testing categories in both Argentina and export markets.
• Abbott Diagnostics: Global IVD multinational with strong molecular (m2000, Alinity m), immunoassay, and point-of-care offerings. Competes head-to-head with Biocientifica in infectious disease and autoimmune diagnostics and has deep presence across Latin America.
• Cepheid (Danaher): Molecular diagnostics specialist behind the GeneXpert platform, dominant in infectious disease RT-PCR. Competes directly with Biocientifica's Schep RT-PCR line for dengue, SARS-CoV-2, influenza, and hospital-based molecular testing customers.

Regional players

• GEMATEC Diagnósticos: Argentine diagnostic products company serving clinical laboratories with reagents and instruments in immunohematology and clinical chemistry. Comparable as a domestic Argentine peer serving similar laboratory customer segments.
• Diagnóstica Internacional (Mexico): Latin American IVD distributor and manufacturer with presence across Mexico, Central America, and parts of South America. Comparable as a regional Latin American diagnostics peer with cross-border distribution capabilities, though operating primarily in Mexican/Central American rather than Southern Cone markets.

Others

• Solis BioDyne: Estonian-based PCR/qPCR enzyme and master mix manufacturer (FIREPol, HOT FIREPol, FIREScript). Directly comparable as a represented principal whose products Biocientifica distributes in Argentina, and a competitive reference point for the molecular biology reagent category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BiocientificaSA
• LinkedInlinkedin.com/company/biocientifica-sa
• Instagraminstagram.com/biocientifica_ar

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biocientifica